Published in:
01-04-2021 | Glaucoma | Letter to the Editor (by invitation)
Response to the letter re “CPAP therapy reduces oxidative stress in patients with glaucoma and OSAS and improves the visual field”
Authors:
Noriko Himori, Toru Nakazawa
Published in:
Graefe's Archive for Clinical and Experimental Ophthalmology
|
Issue 4/2021
Login to get access
Excerpt
We thank Dr. Turnbull and Dr. Heitmar for their comments on our work. Our study recruited glaucoma patients with OSAS whose progression was reliably known both before and after the start of CPAP therapy. Pre-CPAP progression was assessed based on 5 or more sets of reliable HFA data from a 2-year period, and post-CPAP progression was assessed on 5 or more sets of data from a 1.5-year period. All patients used CPAP daily for at least 4 h and did not cease CPAP use during the study period. The apnea-hypopnea index was measured both pre- and post-CPAP in all patients with full-night comprehensive polysomnography. Subjects with high myopia were not excluded, reflecting reports that myopia does not influence glaucoma progression [
1]. …